Bi Ai-xiao, Ding Yuan-sheng, Liu Zhong-hua, Hu Zhong-yi
Department of Microbiology, Medical School, Suzhou University, Suzhou 215123, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2008 Feb;42(2):81-5.
To establish a recombinant plasmid of CFP32 of Mycobacterium tuberculosis in E. coli, and to analyze its antigenicity.
Rv0577 gene was amplified by polymerase chain reaction from genome of Mycobacterium tuberculosis, and then cloned into vector pMD18-T followed by the subclone into the expression vector pET21a. Recombinant CFP32 was expressed and purified. The antigenicity of the recombinant protein was analyzed by using Western-blot. The purified recombinant CFP32 protein was used as an antigen to screen the sera of 7 pulmonary TB patients (n = 97), as well as the other pulmonary disease patients (n = 25), and the clinically healthy controls (n = 38) by ELISA.
Recombinant plasmid of CFP32 was established, and be expressed efficiently in E. coli BL21 (DE3). The relative molecular mass of the protein was about 300,000 by SDS-PAGE analysis. The protein purified by Ni-NTA was in a purity over 90%, which was confirmed by Western-blot analysis. ELISA analysis showed its sensitivity and specificity were 63.9% (62/97) and 96.8% (2/63) respectively.
The recombinant expression plasmid pET21a CFP32 has been constructed and CFP32 proteins has been successfully expressed and be purified in E. coli and, ELISA analysis has identified the recombinant CFP32 as a candidate antigen for TB serodiagnosis.
构建结核分枝杆菌CFP32在大肠杆菌中的重组质粒,并分析其抗原性。
通过聚合酶链反应从结核分枝杆菌基因组中扩增Rv0577基因,然后克隆到载体pMD18-T中,随后亚克隆到表达载体pET21a中。表达并纯化重组CFP32。通过蛋白质免疫印迹分析重组蛋白的抗原性。用纯化的重组CFP32蛋白作为抗原,通过酶联免疫吸附测定法筛选7例肺结核患者(n = 97)、其他肺部疾病患者(n = 25)以及临床健康对照者(n = 38)的血清。
构建了CFP32重组质粒,并在大肠杆菌BL21(DE3)中高效表达。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析,该蛋白的相对分子质量约为300,000。经镍-亚氨基三乙酸纯化的蛋白纯度超过90%,蛋白质免疫印迹分析证实了这一点。酶联免疫吸附测定法分析显示其敏感性和特异性分别为63.9%(62/97)和96.8%(2/63)。
已构建重组表达质粒pET21a-CFP32,CFP32蛋白在大肠杆菌中成功表达并纯化,酶联免疫吸附测定法分析已将重组CFP32鉴定为结核血清学诊断的候选抗原。